Pilot application of iTRAQ to the retinal disease Macular Telangiectasia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Proteome Research

• Publication date

  2012-02-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/pr200889tPMID 22098468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidative stress and the regulation of complement activation in human glaucoma.

  2010cited by this paper
• Baseline Characteristics of Participants in the Natural History Study of Macular Telangiectasia (MacTel) MacTel Project Report No. 2

  2010cited by this paper
• Vitreous Proteomics and Diabetic Retinopathy

  2010cited by this paper
• Peptide Labeling with Isobaric Tags Yields Higher Identification Rates Using iTRAQ 4-Plex Compared to TMT 6-Plex and iTRAQ 8-Plex on LTQ Orbitrap

  2010cited by this paper
• Perifoveal müller cell depletion in a case of macular telangiectasia type 2.

  2010cited by this paper
• Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling.

  2010cited by this paper
• Glycolysis: a bioenergetic or a survival pathway?

  2010cited by this paper
• Metamorphopsia in patients with macular telangiectasia type 2

  2009cited by this paper
• Amyloid- (cid:1) and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice

  2009cited by this paper
• Reading performance is reduced by parafoveal scotomas in patients with macular telangiectasia type 2.

  2009cited by this paper
• Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2.

  2009cited by this paper
• Human retinal pigment epithelium proteome changes in early diabetes

  2008cited by this paper
• Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.

  2008cited by this paper
• iTRAQ experimental design for plasma biomarker discovery.

  2008cited by this paper
• ABNORMAL MACULAR PIGMENT DISTRIBUTION IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA

  2008cited by this paper
• Proteomics as a research tool in clinical and experimental ophthalmology

  2008cited by this paper
• Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

  2007cited by this paper
• The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S

  2007cited by this paper
• Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ).

  2007cited by this paper
• Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis.

  2006cited by this paper
• Idiopathic Macular Telangiectasia

  2006cited by this paper
• Proteomic analysis of vitreous from diabetic macular edema.

  2005cited by this paper
• Metabolic mapping in mammalian retina: a biochemical and 3H-2-deoxyglucose autoradiographic study.

  2003cited by this paper
• Drusen proteome analysis: An approach to the etiology of age-related macular degeneration

  2002cited by this paper
• Mechanisms of Glutamate Metabolic Signaling in Retinal Glial (Müller) Cells

  2000cited by this paper
• Amino acid analysis using precolumn derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate.

  2000cited by this paper
• Histopathologic study of presumed parafoveal telangiectasis.

  1999cited by this paper
• Trafficking of molecules and metabolic signals in the retina.

  1998cited by this paper
• Lactate released by Muller glial cells is metabolized by photoreceptors from mammalian retina

  1995cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis

  1993cited by this paper
• Synthesis of a fluorescent derivatizing reagent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography.

  1993cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

  1993cited by this paper
• Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum

  1982cited by this paper
• Parafoveal retinal telangiectasis: Light and electron microscopy studies

  1980cited by this paper

• Clinical histopathology and pathogenesis of macular telangiectasia type 2.

  2025cites this paper
• Genetic Background of Macular Telangiectasia Type 2

  2025cites this paper
• Metaboloma use in ophthalmology

  2022cites this paper
• Mass spectrometry-based retina proteomics.

  2022cites this paper
• Metabolism Dysregulation in Retinal Diseases and Related Therapies

  2022cites this paper
• Choroidal vascularity index: an enhanced depth optical coherence tomography-based parameter to determine vascular status in patients with proliferative and non-proliferative macular telangiectasia

  2021cites this paper
• Microstructural Changes in Cystoid Macular Edema in Retinitis Pigmentosa after Intravitreal Dexamethasone Implant Injection.

  2020cites this paper
• Evaluation of Choroidal Thickness in Patients with Proliferative and Non-Proliferative Macular Telangiectasia Using Enhanced Depth Imaging Optical Coherence Tomography

  2020cites this paper
• Retinal neuroprotection: current strategies and future directions

  2019cites this paper
• Hypoxia tolerance in the Norrin-deficient retina and the chronically hypoxic brain studied at single-cell resolution

  2019cites this paper
• The Human Eye Proteome Project: Updates on an Emerging Proteome

  2018cites this paper
• Genome-wide analyses identify common variants associated with macular telangiectasia type 2

  2017cites this paper
• Proteome analysis of vitreous humor in retinal detachment using two different flow-charts for protein fractionation.

  2017cites this paper
• Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach

  2016cites this paper
• Vitreous humor in the pathologic scope: Insights from proteomic approaches

  2015cites this paper
• iTRAQ-Based Quantitative Proteomic Analysis of Tear Fluid in a Rat Penetrating Keratoplasty Model With Acute Corneal Allograft Rejection.

  2015cites this paper
• Proteomic analysis of the human vitreous humor in Retinal Detachment

  2015cites this paper
• A New CRB1 Rat Mutation Links Müller Glial Cells to Retinal Telangiectasia

  2015cites this paper
• THE RELATIONSHIP BETWEEN INNER RETINAL CAVITATION, PHOTORECEPTOR DISRUPTION, AND THE INTEGRITY OF THE OUTER LIMITING MEMBRANE IN MACULAR TELANGIECTASIA TYPE 2

  2013cites this paper
• Differential gene expression profiling after conditional Müller-cell ablation in a novel transgenic model.

  2013cites this paper
• Tear fluid protein biomarkers.

  2013cites this paper
• The Human Eye Proteome Project: Perspectives on an emerging proteome

  2013cites this paper
• AAV-Mediated, Optogenetic Ablation of Müller Glia Leads to Structural and Functional Changes in the Mouse Retina

  2013cites this paper
• Macular telangiectasia type 2.

  2013cites this paper
• iTRAQ, a New Prospect of Toxicogenomics

  2013cites this paper
• Anti-retinal antibodies in patients with macular telangiectasia type 2.

  2013cites this paper